Jean Philippe Boulenger

Summary

Country: France

Publications

  1. ncbi request reprint No association between non-violent suicidal behavior and the serotonin transporter promoter polymorphism
    Philippe Courtet
    Department of Psychological Medicine and Psychiatry, Lapeyronie Hospital, INSERM E99 30, Montpellier, France
    Am J Med Genet B Neuropsychiatr Genet 116:72-6. 2003
  2. ncbi request reprint [Anxiety and adjustment disorders]
    Jean Philippe Boulenger
    Service universitaire de psychiatrie adulte, CHU Montpellier, 34295 Montpellier
    Rev Prat 53:1715-22. 2003
  3. ncbi request reprint A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder
    Stuart A Montgomery
    Imperial College, London, UK
    J Clin Psychiatry 66:1270-8. 2005
  4. doi request reprint A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder
    Jean Philippe Boulenger
    CHRU de Montpellier, Universite Montpellier I, Montpellier, France
    J Psychopharmacol 26:1408-16. 2012
  5. ncbi request reprint [Anxiety syndromes: clinical features and classification]
    Jean Philippe Boulenger
    CHU de Montpellier, Hôpital La Colombière, 34295 Montpellier Cedex 5
    Rev Prat 60:777-81. 2010
  6. ncbi request reprint [Rationalizing the prescription of antidepressants]
    Jean Philippe Boulenger
    Service universitaire de psychiatrie adulte et Inserm U 888, CHU de Montpellier, Universite Montpellier 1, 34295 Montpellier Cedex 5
    Rev Prat 58:395-402. 2008
  7. ncbi request reprint [Atypical panic attacks]
    Jean Philippe Boulenger
    Service universitaire de psychiatrie adulte, CHRU de Montpellier et université Montpellier l, 34295 Montpellier Cedex
    Rev Prat 59:495-8. 2009
  8. ncbi request reprint [Emotional consequences of psychological trauma]
    Jean Philippe Boulenger
    Service universitaire de psychiatrie adulte, Hôpital La Colombière, 4295 Montpellier Cedex 5, France
    Rev Prat 59:963-8. 2009
  9. ncbi request reprint A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients
    J P Boulenger
    University Department of Adult Psychiatry, CHU de Montpellier and INSERM E361, France
    Curr Med Res Opin 22:1331-41. 2006
  10. doi request reprint Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine
    J P Boulenger
    CHU de Montpellier, Universite Montpellier 1, France
    Curr Med Res Opin 26:605-14. 2010

Collaborators

Detail Information

Publications36

  1. ncbi request reprint No association between non-violent suicidal behavior and the serotonin transporter promoter polymorphism
    Philippe Courtet
    Department of Psychological Medicine and Psychiatry, Lapeyronie Hospital, INSERM E99 30, Montpellier, France
    Am J Med Genet B Neuropsychiatr Genet 116:72-6. 2003
    ..Thus, the genetically altered expression of the 5-HT transporter might be associated with more severe or violent suicidal behavior, but not with non-violent suicidal behavior...
  2. ncbi request reprint [Anxiety and adjustment disorders]
    Jean Philippe Boulenger
    Service universitaire de psychiatrie adulte, CHU Montpellier, 34295 Montpellier
    Rev Prat 53:1715-22. 2003
  3. ncbi request reprint A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder
    Stuart A Montgomery
    Imperial College, London, UK
    J Clin Psychiatry 66:1270-8. 2005
    ..The present relapse prevention study investigated relapse rates during a 24-week, randomized, double-blind, placebo-controlled period in patients with generalized SAD who had responded to 12-week open-label treatment with escitalopram...
  4. doi request reprint A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder
    Jean Philippe Boulenger
    CHRU de Montpellier, Universite Montpellier I, Montpellier, France
    J Psychopharmacol 26:1408-16. 2012
    ..The withdrawal rates due to adverse events were 8% (open-label), and 3% (placebo) and 8% (Lu AA21004) (double-blind). Thus, Lu AA21004 was effective in preventing relapse of MDD and was well tolerated as maintenance treatment...
  5. ncbi request reprint [Anxiety syndromes: clinical features and classification]
    Jean Philippe Boulenger
    CHU de Montpellier, Hôpital La Colombière, 34295 Montpellier Cedex 5
    Rev Prat 60:777-81. 2010
    ..Early diagnosis and treatment of anxiety disorders are crucial since they represent an important risk factor for the secondary development of depressive episodes...
  6. ncbi request reprint [Rationalizing the prescription of antidepressants]
    Jean Philippe Boulenger
    Service universitaire de psychiatrie adulte et Inserm U 888, CHU de Montpellier, Universite Montpellier 1, 34295 Montpellier Cedex 5
    Rev Prat 58:395-402. 2008
    ..The recommended duration of treatment for a depressive episode is six months and the medication should he tapered off progressively in order to avoid withdrawal symptoms...
  7. ncbi request reprint [Atypical panic attacks]
    Jean Philippe Boulenger
    Service universitaire de psychiatrie adulte, CHRU de Montpellier et université Montpellier l, 34295 Montpellier Cedex
    Rev Prat 59:495-8. 2009
    ..The semiological analysis of these attacks, their clinical background and their occurrence in young adults, mostly women, will contribute to the right diagnosis of these emotional reactions so frequent in general practice...
  8. ncbi request reprint [Emotional consequences of psychological trauma]
    Jean Philippe Boulenger
    Service universitaire de psychiatrie adulte, Hôpital La Colombière, 4295 Montpellier Cedex 5, France
    Rev Prat 59:963-8. 2009
    ..Apart from specific psychiatric syndromes the treatment of adjustment disorders will rely mainly on social and psychological interventions; the use of psychotropic drugs will be prudent and limited in time...
  9. ncbi request reprint A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients
    J P Boulenger
    University Department of Adult Psychiatry, CHU de Montpellier and INSERM E361, France
    Curr Med Res Opin 22:1331-41. 2006
    ..This randomised, double-blind, fixed-dose study evaluated the efficacy of escitalopram and paroxetine in the long-term treatment of severely depressed patients with major depressive disorder (MDD)...
  10. doi request reprint Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine
    J P Boulenger
    CHU de Montpellier, Universite Montpellier 1, France
    Curr Med Res Opin 26:605-14. 2010
    ..To investigate if treatment outcome for severely depressed patients depends on their baseline level of anxiety...
  11. ncbi request reprint Residual symptoms of depression: clinical and theoretical implications
    Jean Philippe Boulenger
    University Department of Adult Psychiatry, CHU de Montpellier, 34295 Montpellier Cedex 5, France
    Eur Psychiatry 19:209-13. 2004
    ....
  12. doi request reprint A further evaluation of decision-making under risk and under ambiguity in schizophrenia
    Guillaume Fond
    Universite Montpellier 1, Montpellier, France
    Eur Arch Psychiatry Clin Neurosci 263:249-57. 2013
    ..Lower gains on the GDT were associated with executive dysfunctioning in schizophrenia. These findings give evidence that schizophrenia patients display impairments in both decision-making under ambiguity and under risk...
  13. ncbi request reprint Competence to consent and insight in schizophrenia: is there an association? A pilot study
    Delphine Capdevielle
    University Department of Adult Psychiatry, Hôpital de la Colombière, CHU Montpellier, University Montpellier 1, France
    Schizophr Res 108:272-9. 2009
    ..The aim of this study was to explore the correlations existing between the competence to consent to treatment and the level of awareness of the disease (insight) in patients suffering from schizophrenia in a cross-sectional study...
  14. ncbi request reprint [French adaptation and validation of the scale to assess unawareness of mental disorder]
    Stéphane Raffard
    Docteur en Psychologie Clinique, Hôpital de la Colombière, CHU Montpellier, Universite de Montpellier, France
    Can J Psychiatry 55:523-31. 2010
    ..To validate the French version of the Scale to Assess Unawareness of Mental Disorder (SUMD) in patients with schizophrenia...
  15. ncbi request reprint Frequent attendance in family practice and common mental disorders in an open access health care system
    Joanna Norton
    INSERM, U1061, Montpellier, France
    J Psychosom Res 72:413-8. 2012
    ..However little is known about specific psychiatric disorders and whether this behavior extends to specialist services, in an open access fee-for-service health care system...
  16. doi request reprint Insight and executive functioning in schizophrenia: a multidimensional approach
    Stéphane Raffard
    University Department of Adult Psychiatry, CHU, Universite Montpellier 1, France
    Psychiatry Res 167:239-50. 2009
    ..The analysis indicates that poor insight in schizophrenia may be partially related to executive dysfunction. Finally, our study emphasizes the possible role of neuropsychological intervention in improving patients' insight into illness...
  17. ncbi request reprint Impaired ability to imagine future pleasant events is associated with apathy in schizophrenia
    Stéphane Raffard
    Laboratory Epsylon, EA 4556, Montpellier, France University Department of Adult Psychiatry, CHU Montpellier, Montpellier, France Electronic address
    Psychiatry Res 209:393-400. 2013
    ..These results suggest that episodic future thinking impairments, especially for future events of pleasure, may partly underlie the motivational deficits characteristic of schizophrenia. ..
  18. doi request reprint The mental health of doctor-shoppers: experience from a patient-led fee-for-service primary care setting
    Joanna Norton
    INSERM U888, Pathologies of the Nervous System, Montpellier, France
    J Affect Disord 131:428-32. 2011
    ....
  19. doi request reprint A multi-dimensional approach to insight and its evolution in first-episode psychosis: a 1-year outcome naturalistic study
    Delphine Capdevielle
    University Department of Adult Psychiatry, CHU Montpellier, University Montpellier 1, Hôpital La Colombière, 39 Avenue Charles Flahault, 34295 Montpellier Cedex 5, France Inserm U1061, Hôpital La Colombière, Pavillon 42, 39 Avenue Charles Flahault, 34295 Montpellier, France Electronic address
    Psychiatry Res 210:835-41. 2013
    ..This could be useful for developing psychotherapeutic programmes acting upon the different aspects of insight. ..
  20. doi request reprint Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (the ESPRIT study)
    Marie Laure Ancelin
    Institut de la Santé et de la Recherche Médicale Inserm and University of Montpellier 1, Hôpital La Colombière, Centre hospitalier universitaire CHU, Montpellier, France
    Biol Psychiatry 68:125-32. 2010
    ..Lipids appear to mediate depressive vulnerability in the elderly; however, sex differences and genetic vulnerability have not been taken into account in previous prospective studies...
  21. doi request reprint Extended duration of hospitalization in first episode psychosis: an evaluation of its clinical justification
    Delphine Capdevielle
    Department of Adult Psychiatry, La Colombière Hospital, CHU de Montpellier, University Montpellier 1, 34095 Montpellier Cedex 5, France
    Psychiatry Res 209:160-6. 2013
    ....
  22. pmc Impairments of social motor coordination in schizophrenia
    Manuel Varlet
    Movement to Health Laboratory, EuroMov, Montpellier 1 University, Montpellier, France
    PLoS ONE 7:e29772. 2012
    ..Our study thus identified relational motor signatures of schizophrenia and opens new perspectives for detecting the illness and improving social interactions of patients...
  23. ncbi request reprint Can individuals with schizophrenia be instructed to deliberately feign memory deficits?
    Stéphane Raffard
    a Laboratory Epsylon, University Montpellier 3, EA 4425, Boulevard Henri IV, Montpellier, France
    Cogn Neuropsychiatry 19:414-26. 2014
    ....
  24. ncbi request reprint Use of the PRIME-MD Patient Health Questionnaire for estimating the prevalence of psychiatric disorders in French primary care: comparison with family practitioner estimates and relationship to psychotropic medication use
    Joanna Norton
    Institut National de la Sante et de la Recherche Medicale INSERM, U888, Hôpital La Colombière, Pavillon 42, 39 av Charles Flahault, BP 34493, 34093 Montpellier Cedex 5, France
    Gen Hosp Psychiatry 29:285-93. 2007
    ....
  25. doi request reprint Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal
    Céline Eiden
    Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France
    J Addict Med 5:302-3. 2011
    ..So, it seems important to rapidly detect drugs taken by patients with mental agitation, to optimize management and minimize complications related to drugs...
  26. doi request reprint Insight is not associated with insensitivity to future consequences in schizophrenia
    Stéphane Raffard
    Universites Montpellier 1, Montpellier 3 et St Etienne, France
    Psychiatry Res 187:307-9. 2011
    ..No association was found between insight and IGT scores. Our results suggest that impaired decision-making ability in schizophrenia patients cannot be solely predicted by lack of insight...
  27. doi request reprint Exploring self-defining memories in schizophrenia
    Stéphane Raffard
    Department of Adult Psychiatry, University of Geneva, Switzerland
    Memory 17:26-38. 2009
    ..Furthermore, the findings suggest that impairments in extracting meaning from personal memories could represent a core disturbance of autobiographical memory in patients with schizophrenia...
  28. doi request reprint Narrative identity in schizophrenia
    Stéphane Raffard
    Cognitive Psychopathology and Neuropsychology Unit, University of Geneva, Geneva, Switzerland
    Conscious Cogn 19:328-40. 2010
    ..Our results suggest that schizophrenia patients have difficulties to organize and extract meaning from their past experiences in order to create coherent personal narratives...
  29. ncbi request reprint Memory self-efficacy in schizophrenia
    Stéphane Raffard
    Epsylon Laboratory Dynamic of Human Abilities and Health Behaviors, University of Montpellier 3, Montpellier, France University Department of Adult Psychiatry, Hôpital de la Colombière, CHRU Montpellier, Montpellier 1 University, Montpellier, France Electronic address
    Schizophr Res 156:56-9. 2014
    ..Among controls, but not patients, MSE was positively related to memory performance. This result suggests that normal relationship between MSE and memory functioning is disrupted in schizophrenia. ..
  30. doi request reprint Dissociating self-reported cognitive complaint from clinical insight in schizophrenia
    Sophie Bayard
    Sleep Disorder Unit, University Department of Neurology, University of Montpellier 1, 34295 Montpellier, Cedex 5, France
    Eur Psychiatry 24:251-8. 2009
    ..Assessment of cognitive complaint and awareness of illness need to be assessed before engagement in rehabilitation program...
  31. doi request reprint Persistence of abnormal cortisol levels in elderly persons after recovery from major depression
    Isabelle Beluche
    INSERM, U888, Montpellier, France
    J Psychiatr Res 43:777-83. 2009
    ....
  32. doi request reprint Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database
    Helene Peyriere
    Medical Pharmacology and Toxicology Department, Lapeyronie Hospital, CHU Montpellier, France
    Pharmacoepidemiol Drug Saf 18:948-55. 2009
    ..First- and second-generation antipsychotics commonly cause mild gastrointestinal hypomotility. Intestinal necrosis may be a consequence of such gastrointestinal perturbations...
  33. pmc Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder
    Jean Philippe Boulenger
    aUniversity Department of Adult Psychiatry, CHU de Montpellier, Montpellier, France bH Lundbeck A S, Copenhagen, Denmark
    Int Clin Psychopharmacol 29:138-49. 2014
    ..No clinically relevant changes were seen in clinical safety laboratory values, weight, ECG or vital signs parameters. Vortioxetine was efficacious and well tolerated in the treatment of patients with major depressive disorder...
  34. ncbi request reprint [Mental handicap. Administrative supervision, trusteeship, safeguard of justice]
    Françoise Causse
    Service universitaire de psychiatrie adulte, CHRU La Colombière, Montpellier
    Rev Prat 57:1823-8. 2007
  35. ncbi request reprint Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes
    Isabelle Chaudieu
    INSERM, U888, Montpellier, F 34093 France
    J Affect Disord 106:307-13. 2008
    ..Cortisol secretion in elderly persons with anxiety disorders exposed to common stressful situations has not been evaluated...
  36. doi request reprint Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone
    P M Llorca
    Centre Hospitalier Universitaire, Psychiatrie B, Place Henri Dunand, 63003 Clermont Ferrand Cedex 1, France
    Encephale 34:170-8. 2008
    ..To investigate the efficacy and tolerability of direct initiation of long-acting injectable risperidone (LAIR) in adults with schizophrenia or other psychotic disorders requiring a change of treatment...